Extent of Drug Patents With Terminal Disclaimers and Obviousness-Type Double Patenting Rejections

Extent of Drug Patents With Terminal Disclaimers and Obviousness-Type Double Patenting Rejections

This study evaluates the frequency of terminal disclaimers filed by drug patent holders to obviate obviousness-type double patenting rejections associated with drug patent thickets.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 2024-09, Vol.332 (10), p.837-838
Hauptverfasser: Tu, S. Sean, Kesselheim, Aaron S, Chao, Bernard
Format: Artikel
Sprache:eng
Schlagworte:
Drug Industry
Patents as Topic
United States
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This study evaluates the frequency of terminal disclaimers filed by drug patent holders to obviate obviousness-type double patenting rejections associated with drug patent thickets.
ISSN:0098-7484
1538-3598
1538-3598
DOI:10.1001/jama.2024.14350